Healthcare providers are also integrating semaglutide into broader metabolic care strategies, since obesity is closely linked with cardiometabolic disorders such as type 2 diabetes and cardiovascular disease
Mann JFE, Rossing P, Bakris G et al (2024) Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
This would seem to put people back into the viscous cycle of weight loss and regain
The exception to that is found, however, in many disease states (including hyper- and hypo-thyroid states), as well as in conditions relating to specific types of diets (high-fat, high-protein, and low-carb)
Any effect is gradual and works best alongside good sleep habits, nutrition, and training
Its broad signaling profile makes it a relevant compound in advanced research focused on cellular communication, regulatory mechanisms, and systemic biological responses